News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Orexigen Therapeutics, Inc. Sets IPO at 6 Million Shares, $11-$13 Each
April 10, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, April 9 (Reuters) - Biopharmaceutical company Orexigen Therapeutics on Monday said it is planning an initial public offering of 6 million shares for between $11 and $13 per share.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Podcast
Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds
May 27, 2026
·
2 min read
·
Jef Akst
Manufacturing
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant
May 26, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & Acquisitions
Lilly lands vaccine trifecta with 3 new biotech buys valued at up to $3.8B
May 26, 2026
·
5 min read
·
Annalee Armstrong
Funding
Recordati fields $12.4B go-private offer
May 22, 2026
·
2 min read
·
Tristan Manalac
